In in vivo study, we have also observed that administration of miR-335 mimic could bring about a decrease in expression of Hif-1α and consequently a reduction in infarct volume in the early time of cerebral ischemia whereas administration of anti miR-335 could reduce infarct volume in the late time of cerebral ischemia. Here, HIF1A is linked to brain ischemia.